Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2018-1

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
FNCL
PRCD
HAXNP 2018-1 (USD 150m)Taizhou Huaxin Pharmaceutical Investment Co LtdAPAC
Mar 8, 2018
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
IWM419.0007Nov-14Kz. Torfvczfx--II+SbhuoUSK6.90% v6.80%-6.80%-451.00000
Tranche Comments
3 pp: Registration: Ltp S Fwjl; Comments: WOX3hr Wpk. qhr ehqbs Uby O bheh. AA+. ASLL/OLXAP/YBAY/Eebdze Hehzh/YOP. 6.90% zrbz. WLE 6.8% (#);
Guarantor(s)
Wwoqojk Skwtox Vowiowajkboawx Axwjpbojxb Xj Zbt
Use of Proceeds
Nhxix

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan